Copyright Reports & Markets. All rights reserved.

Global Shengagliptin Phosphate Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Shengagliptin Phosphate Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 50mg
    • 1.3.3 100mg
  • 1.4 Market Analysis by Dosage Form
    • 1.4.1 Overview: Global Shengagliptin Phosphate Tablets Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
    • 1.4.2 Conventional Tablets
    • 1.4.3 Immediate-release Oral Tablets
  • 1.5 Market Analysis by Combination Therapy
    • 1.5.1 Overview: Global Shengagliptin Phosphate Tablets Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
    • 1.5.2 Combined With Metformin
    • 1.5.3 Combined With Sulfonylureas
  • 1.6 Market Analysis by Sales Channel
    • 1.6.1 Overview: Global Shengagliptin Phosphate Tablets Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Retail
    • 1.6.4 Online
  • 1.7 Market Analysis by Application
    • 1.7.1 Overview: Global Shengagliptin Phosphate Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Type 2 Diabetes Treatment
    • 1.7.3 Blood Glucose Control
    • 1.7.4 Chronic Disease Management
    • 1.7.5 Others
  • 1.8 Global Shengagliptin Phosphate Tablets Market Size & Forecast
    • 1.8.1 Global Shengagliptin Phosphate Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.8.2 Global Shengagliptin Phosphate Tablets Sales Quantity (2021-2032)
    • 1.8.3 Global Shengagliptin Phosphate Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Cgenetech
    • 2.1.1 Cgenetech Details
    • 2.1.2 Cgenetech Major Business
    • 2.1.3 Cgenetech Shengagliptin Phosphate Tablets Product and Services
    • 2.1.4 Cgenetech Shengagliptin Phosphate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Cgenetech Recent Developments/Updates

3 Competitive Environment: Shengagliptin Phosphate Tablets by Manufacturer

  • 3.1 Global Shengagliptin Phosphate Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Shengagliptin Phosphate Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Shengagliptin Phosphate Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Shengagliptin Phosphate Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Shengagliptin Phosphate Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Shengagliptin Phosphate Tablets Manufacturer Market Share in 2025
  • 3.5 Shengagliptin Phosphate Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Shengagliptin Phosphate Tablets Market: Region Footprint
    • 3.5.2 Shengagliptin Phosphate Tablets Market: Company Product Type Footprint
    • 3.5.3 Shengagliptin Phosphate Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Shengagliptin Phosphate Tablets Market Size by Region
    • 4.1.1 Global Shengagliptin Phosphate Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Shengagliptin Phosphate Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Shengagliptin Phosphate Tablets Average Price by Region (2021-2032)
  • 4.2 North America Shengagliptin Phosphate Tablets Consumption Value (2021-2032)
  • 4.3 Europe Shengagliptin Phosphate Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Shengagliptin Phosphate Tablets Consumption Value (2021-2032)
  • 4.5 South America Shengagliptin Phosphate Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Shengagliptin Phosphate Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Shengagliptin Phosphate Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Shengagliptin Phosphate Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Shengagliptin Phosphate Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Shengagliptin Phosphate Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Shengagliptin Phosphate Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Shengagliptin Phosphate Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Shengagliptin Phosphate Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Shengagliptin Phosphate Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Shengagliptin Phosphate Tablets Market Size by Country
    • 7.3.1 North America Shengagliptin Phosphate Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Shengagliptin Phosphate Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Shengagliptin Phosphate Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Shengagliptin Phosphate Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Shengagliptin Phosphate Tablets Market Size by Country
    • 8.3.1 Europe Shengagliptin Phosphate Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Shengagliptin Phosphate Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Shengagliptin Phosphate Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Shengagliptin Phosphate Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Shengagliptin Phosphate Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Shengagliptin Phosphate Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Shengagliptin Phosphate Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Shengagliptin Phosphate Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Shengagliptin Phosphate Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Shengagliptin Phosphate Tablets Market Size by Country
    • 10.3.1 South America Shengagliptin Phosphate Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Shengagliptin Phosphate Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Shengagliptin Phosphate Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Shengagliptin Phosphate Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Shengagliptin Phosphate Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Shengagliptin Phosphate Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Shengagliptin Phosphate Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Shengagliptin Phosphate Tablets Market Drivers
  • 12.2 Shengagliptin Phosphate Tablets Market Restraints
  • 12.3 Shengagliptin Phosphate Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Shengagliptin Phosphate Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Shengagliptin Phosphate Tablets
  • 13.3 Shengagliptin Phosphate Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Shengagliptin Phosphate Tablets Typical Distributors
  • 14.3 Shengagliptin Phosphate Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Shengagliptin Phosphate Tablets market size was valued at US$ 12.86 million in 2025 and is forecast to a readjusted size of US$ 59.03 million by 2032 with a CAGR of 12.5% during review period.
    Sentagliptin Phosphate Tablets are a Class 1 innovative oral hypoglycemic drug independently developed in China, belonging to high‑selectivity DPP‑4 inhibitors. By inhibiting the activity of dipeptidyl peptidase 4, the drug delays the degradation of incretins in the human body and bidirectionally regulates the secretion of insulin and glucagon, so as to steadily control blood glucose levels. It exerts a mild hypoglycemic effect with a low risk of hypoglycemia and favorable medication safety and tolerance. It is mainly applied to improve blood glucose control in adult patients with type 2 diabetes, and can be used as monotherapy or in combination with hypoglycemic agents such as metformin. As a newly launched domestic innovative metabolic drug, Sentagliptin Phosphate Tablets diversify the clinical treatment options for type 2 diabetes in China and meet the long‑term management needs of chronic diseases. Supported by clinical promotion and favorable medical policies, it enjoys promising development prospects in the hypoglycemic drug market.In 2025, global Sentagliptin Phosphate Tablets production reached approximately 1.6 million bottles.
    Sentagliptin Phosphate Tablets are a Class 1 innovative DPP-4 inhibitor independently developed in China. Relying on excellent clinical efficacy and safety, it has outstanding market competitiveness in the treatment of type 2 diabetes. As a new generation of highly selective preparation, the drug features an extremely low risk of hypoglycemia and good tolerance. It meets the clinical needs of elderly patients and those with combined high-risk factors. Meanwhile, it supports flexible combined medication regimens and can be used synergistically with a variety of hypoglycemic drugs, expanding clinical application scenarios. Supported by the National Major New Drug Creation Special Project, it enjoys a long patent protection period and a stable market life cycle. At present, the domestic DPP-4 inhibitor market faces fierce competition with coexisting imported original drugs and domestic generic drugs. As an innovative drug with differentiated advantages, Sentagliptin Phosphate Tablets is expected to gradually increase its market share through medical insurance access, clinical academic promotion and grassroots market penetration. With the growing demand for chronic disease management of diabetes and the continuous release of policy dividends for innovative drugs, this product will further enrich clinical treatment options, accelerate the import substitution of domestic innovative hypoglycemic drugs, and present remarkable long-term market development potential.
    This report is a detailed and comprehensive analysis for global Shengagliptin Phosphate Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Shengagliptin Phosphate Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Shengagliptin Phosphate Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Shengagliptin Phosphate Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Shengagliptin Phosphate Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Shengagliptin Phosphate Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Shengagliptin Phosphate Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cgenetech, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Shengagliptin Phosphate Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    50mg
    100mg
    Market segment by Dosage Form
    Conventional Tablets
    Immediate-release Oral Tablets
    Market segment by Combination Therapy
    Combined With Metformin
    Combined With Sulfonylureas
    Market segment by Sales Channel
    Hospital
    Retail
    Online
    Market segment by Application
    Type 2 Diabetes Treatment
    Blood Glucose Control
    Chronic Disease Management
    Others
    Major players covered
    Cgenetech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Shengagliptin Phosphate Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Shengagliptin Phosphate Tablets, with price, sales quantity, revenue, and global market share of Shengagliptin Phosphate Tablets from 2021 to 2026.
    Chapter 3, the Shengagliptin Phosphate Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Shengagliptin Phosphate Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Shengagliptin Phosphate Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Shengagliptin Phosphate Tablets.
    Chapter 14 and 15, to describe Shengagliptin Phosphate Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now